Medtronic BRC

Quick facts

Marketed products

• Diuretic Increase (DI) · Cardiovascular
  Diuretic Increase (DI) is a device-based therapy from Medtronic that enhances diuretic efficacy, likely through optimized drug delivery or physiological modulation to increase urine output.
• Diuretic Suspension (DS) · Cardiovascular
  Diuretic Suspension promotes fluid and electrolyte excretion through the kidneys to reduce fluid overload and blood pressure.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Medtronic BRC portfolio CI brief
• Medtronic BRC pipeline updates RSS